Inquiry, page-8

Hi mate welcome to the UNS train.
I rarely post but thought I could offer a small insight into this company.

If you have only just stumbled upon this stock by luck, consider yourself very lucky and the term 'in the right place at the right time' comes to mind. Many of us have been invested in this stock for 10years and although the ride hasn't always been as planned, the destination has only gotten grander over the years. The share price does not reflect the potential of this company, nor the progress that has been made. As an investor in spec stocks for several decades , I have never seen a stock with such massive upside and over the last year the down side has been dramatically reduced.

To begin , I guess the best place to start would be there products that unilife has developed and are currently producing.
Several of these products have 15year contracts signed with world leading pharmasutical companies.
These are in no particular order and is not a complete list:











http://youtu.be/ZRzUEc7qfiQ

http://youtu.be/MlnnMrWiJfg

http://youtu.be/PlQr-jGZ5EI

Most are only short clips and will give an indication of the technology at hand and why they are leading the way in the injectable delivery market.

So if things are so rosy , why aren't they already running?

This is a good question and prob not one I can answer comprehensively..
One major factor is the duel listing on the Nasdaq .the Nasdaq can be ruthless , cash is king and the bottom line cash position can be viewed very black and white.. Unilife burns more cash than they bring in (currently) and due to the large amount of time and money required to bring medical devices to market , a lot of smart money is on the side lines waiting for the money flow to look more favorable. They would rather pay a premium down the track rather than invest now and with the potential billion dollar a year income one could argue there is plenty of juice left even if one waits.. I personally don't share this sentiment and have the majority of my portfolio on this baby.another reason is many funds are unable to invest in 'penny stocks' so whilst it is under $5 on the Nasdaq , it isn't receiving the coverage it otherwise would.
Finally , and the most major factor is the large short interest in this stock.i won't elaborate with figures but it's around 30% which is massive when u take into consideration the large holdings by institutions and largest share holders. There are actually more shares short than are available on the open market which would make one wonder how long it will be till a short squeeze.

I'm not nearly as experienced or as knowledgable as some of the posters here, so hopefully they can elaborate on some finer details ..I thought I'd offer a broad perspective.

In my opinion , this sector is the sector with the largest growth potential in the coming years and this is the diamond in the rough. The one that it's possible to get in on the ground floor.
Although this may be viewed as high risk by some conservative investors, one could take peace of mind from the fact that the 2nd largest pharma in the world (sanofi) did all their research and put their money and their future eggs in the unilife basket. Orbimed last year committed 110million dollars in  funding after an extensive audit. Irvine dis apparently the leader in medical device investments and one wouldn't expect them to throw their money at a long shot.

All above was written quickly and is as accurate as I could make it without researching exact figuires.
In my opinion this thing is a rocket and it's take off is inevitable. It may take another 2monrhs or 2 years , but I for one will not be on the sidelines when it does.i have all my
Family and friends on it.

Hope it helps
N2C